Medicine for treating pulmonary interstitial fibrosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A pulmonary interstitial fibrosis and drug technology, which is applied in the directions of drug combinations, medical raw materials derived from angiosperm subphylum, and pharmaceutical formulations, can solve problems such as increasing toxicity and prolonging the effect of cocaine, and achieves the effect of high cure rate.
Inactive Publication Date: 2016-04-20
陈一其
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
① Dyspnea Exertional dyspnea with progressive aggravation, shallow and fast breathing, nasal flapping and accessory muscles may participate in breathing, but most
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Example Embodiment
[0043] Example 1
[0044] Weighing: 15 grams of medlar, 12 grams of mother chrysanthemum, 25 grams of mopancao, 9 grams of centipede, 12 grams of sharp medicine flower, 15 grams of canned vegetables, 15 grams of Tinglizi, 10 grams of hibiscus flower, 12 grams of horse hail gram, spoon leaf grass 8 grams; add 8 times the amount of water, decoct for 1.5 hours, filter; add 6 times the amount of water to the residue, decoct for 1 hour, filter; combine the filtrates, concentrate to 120 grams, which is in line with the daily dosage of normal adults decoction.
[0045] For the treatment of pulmonary fibrosis. Take it orally once a day.
Example Embodiment
[0046] Example 2
[0047]Weighing: 15 grams of medlar, 12 grams of mother chrysanthemum, 25 grams of mopancao, 9 grams of centipede, 12 grams of sharp medicine flower, 15 grams of canned vegetables, 15 grams of Tinglizi, 10 grams of hibiscus flower, 12 grams of horse hail gram, spoon leaf grass 8 grams; add 10 times the amount of water, decoct for 2 hours, filter; add 8 times the amount of water to the residue, decoct for 1.5 hours, filter; combine the filtrates, concentrate, dry, pack, that is, it meets the normal adult one day Dosage of powder.
[0048] For the treatment of pulmonary fibrosis. Take it orally, take it twice a day in the morning and evening.
Example Embodiment
[0049] Example 3
[0050] Weighing: 15 grams of medlar, 12 grams of mother chrysanthemum, 25 grams of mopancao, 9 grams of centipede, 12 grams of sharp medicine flower, 15 grams of canned vegetables, 15 grams of Tinglizi, 10 grams of hibiscus flower, 12 grams of horse hail gram, spoon leaf grass 8 grams; add 6 times the amount of water, decoct 3 times, 1 hour each time, combine the decoction liquid, concentrate, dry, put into the capsule shell, that is, a capsule that meets the daily dosage of a normal adult .
[0051] For the treatment of pulmonary fibrosis. Take it orally, and take it three times a day in the morning, afternoon and evening.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicine for treating pulmonary interstitial fibrosis. The medicine is prepared from the following medicinal raw materials in parts by weight: 15 parts of Chinese wolfberry fruits, 12 parts of matricaria chamomilla, 25 parts of abutilon indicum, 9 parts of Peliosanthes minor Yamamoto, 12 parts of aechmanthera tomentosa nees, 15 parts of viola verecunda, 15 parts of semen lepidii, 10 parts of hibiscus rosa-sinensis, 12 parts of Indian zehneria herb and 8 parts of latouchea fokiensis. According to the medicine, Chinese wolfberry fruits have the effects of warmly invigorating kidney yang; matricaria chamomilla has the effects of clearing heat, removing toxicity and relieving cough and asthma; abutilon indicum has the effects of expelling wind, clearing heat, eliminating phlegm and relieving cough; Peliosanthes minor Yamamoto has the effects of eliminating phlegm, relieving cough, resolving depression and removing blood stasis; aechmanthera tomentosa nees has the effects of tonifying qi and deficiency; viola verecunda has the effects of facilitating lung, eliminating phlegm, relieving sore-throat, expelling pus, benefiting five organs, tonifying qi and blood, tonifying five consumptions and nourishing qi; semen lepidii has the effects of purging lung, soothing asthma, inducing diuresis and diminishing swelling; hibiscus rosa-sinensis has the effects of clearing lung, cooling blood, drying dampness and removing toxicity; Indian zehneria herb has the effects of clearing heat, removing toxicity and eliminating stagnation and phlegm; and latouchea fokiensis has the effects of promoting blood circulation to remove stasis, clearing heat and relieving cough. The medicinal raw materials are combined to achieve the effects of tonifying lung and kidneys, eliminating phlegm, promoting blood circulation and relieving cough and asthma. Clinical experiments prove that the traditional Chinese medicine can be used for safely and effectively treating pulmonary interstitial fibrosis.
Description
technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating pulmonary interstitial fibrosis. Background technique [0002] Prominent symptoms of pulmonary fibrosis are wheezing, coughing, and shortness of breath aggravated by exercise. It is an inflammatory disease of the pulmonary interstitium caused by a variety of reasons. The lesions mainly involve the pulmonary interstitium, but can also involve alveolar epithelial cells and pulmonary blood vessels. Some causes are clear, some are not. Definite causes include inhalation of inorganic dust such as asbestos and coal, organic dust such as mildew dust and cotton dust, gases such as soot and sulfur dioxide, infection by viruses, bacteria, fungi and parasites, drug effects and radiation damage. The descriptions about the symptoms of this disease in traditional Chinese medicine are scattered in diseases such as "pulmonary atrophy", "pulmonary obstruction", "asthma",...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.